Multidisciplinary management of HCC

References

[1] Reig M,Sanduzzi-Zamparelli M,Forner A.et al. BCLC strategy for prognosis prediction and treatment recommendations: the 2026 update J Hepatol. 2026 84 631 54

[2] Vitale A,Cabibbo G,Iavarone M.et al. HCC Special Interest Group of the Italian Association for the Study of the Liver Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept Lancet Oncol. 2023 24 e312 22

[3] Vitale A,Brancaccio G,Miele L.et al. HCC Special Interest Group of the Italian Association for the Study of the Liver (AISF) The multiparametric therapeutic hierarchy: a multidisciplinary approach to HCC management Hepatoma Res. 2025 11 26

[4] Lai Q,Centonze L,Renzulli M.et al. Group the Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest Importance of critical tumor features in multidisciplinary multi-parametric assessment of HCC Hepatoma Res. 2025 11 14

[5] Masarone M,Cabibbo G,Pravisani R.et al. ; the Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest Group. The importance of patient fitness in expert and multidisciplinary multiparametric management of HCC: a narrative review Hepatoma Res. 2025 11 21

[6] Tovoli F,Crocetti L,Mazzarelli C.et al. ; on behalf of the AISF HCC Special Interest Group. Converse therapeutic hierarchy in hepatocellular carcinoma Hepatoma Res. 2026 12 6

[7] Govoni I,Padoan V,Vitale A.et al. ; on behalf of the HCC Special Interest Group of the Italian Association for the Study of the Liver. The role of “treatment unfeasibility” in the multiparametric, multidisciplinary, and expert evaluation of HCC patients Hepatoma Res. 2026 12 10

[8] Vitale A,Piscaglia F,Sangiovanni A.et al. ; ITA.LI.CA Study Group. The Yin-Yang of HCC management: reconciling therapeutic hierarchy and transplant benefit in real-world evidence Liver Transpl. 2026 32 638 41

[9] Abdelhamed W,El-Kassas M. Integrating artificial intelligence into multidisciplinary evaluations of HCC: opportunities and challenges Hepatoma Res. 2025 11 8

[10] Lani L,Zaccherini G,Giannini EG,Trevisani F. Surveillance for patients at risk of hepatocellular carcinoma: how to improve its cost-effectiveness and expand the role of multidisciplinary tumor board? Hepatoma Res. 2025 11 9